Caradigm and MEDai Align to Help Healthcare Organizations Manage Risk, Optimize Care and Improve Population Health Caradigm to integrate MEDai's industry-leading predictive clinical analytic solutions with data aggregation and care management solutions
BELLEVUE, Wash., Oct. 15, 2013 /PRNewswire/ -- Caradigm announced today it has signed an agreement with MEDai, a leader in predictive clinical analytic solutions, designed to give healthcare organizations the comprehensive set of tools they need to effectively manage risk, optimize care management, and improve the health outcomes of populations. MEDai is a LexisNexis company.
Under the agreement, Caradigm will enrich its population health solutions with the predictive clinical analytics capabilities of MEDai's solution, enabling customers to stratify patient populations according to severity, disease state, cost or risk profile. This will allow risk-bearing organizations to use their network of resources to focus care on those who will benefit most, helping create a positive impact on overall health outcomes and total cost of care. When coupled with Caradigm® Care Management software, providers can develop personalized care plans that specify problems, goals and interventions, and manage patients and conditions through timely interventions enabled by near real-time, event-based alerts.
"Healthcare organizations taking on risk need sophisticated analytics and modeling capabilities to help them drive the most effective care programs," said Brian Drozdowicz, vice president of Population Health at Caradigm. "The agreement with MEDai will enable us to offer customers best-of-breed predictive analytics and risk management tools to drive effective, timely decisions about the optimal care for patients. We're excited about the power of this solution to help organizations improve outcomes and reduce costs — and transition successfully to value-based or accountable care models."
"Combining up-to-date clinical data with a patient's claims data is essential to enabling the best decisions about care — and a powerful differentiator of the Caradigm and MEDai solution," said Peter Edelstein, MD, Chief Medical Officer, MEDai. "Together, our predictive and analytics tools will give customers unparalleled insight into patients and populations and make it easy for them to manage risk."
MEDai's solution uses statistical algorithms to identify and risk-stratify patients based on a wide range of factors, including: severity of illness, patient motivation and compliance with evidence-based care guidelines, risk of inpatient admission or emergency department visit, and the total cost of care based on the number of conditions, prescriptions and type of care required.
Customers gain the following insight about populations and individual patients:
- A total risk score, with the ability to change the relative weighting of the scores that make up the aggregate score
- Patient stratification based on risk drivers, i.e., the specific elements causing a patient or cohort to be ranked at a certain risk level
- The directional trend of the risk drivers for that patient or cohort (increasing or decreasing)
- Trends, e.g., medication adherence, that can be addressed across multiple patients
- Costs associated with risk factors and no intervention
- Quantification of possible savings associated with each intervention
This data is presented within Caradigm Care Management, helping care managers take the appropriate actions to put patients on track to improving their health and reducing the cost of care.
Caradigm Care Management was developed in partnership with Geisinger Health Plan, a leader in population health management widely recognized for its innovative case management models and pioneering use of incentive-based wellness programs. Caradigm Care Management helps healthcare organizations manage the care of populations to improve outcomes and the patient experience while helping reduce costs.
Caradigm is a healthcare analytics and population health company dedicated to helping organizations improve care, reduce costs and manage risk. Caradigm analytics solutions provide insight into patients, populations and performance, enabling healthcare organizations to understand their clinical and financial risk and identify the actions needed to address it. Caradigm population health solutions enable teams to deliver the appropriate care to patients through effective coordination and patient engagement, helping to improve outcomes and financial results. The key to Caradigm analytics and population health solutions is a rich set of clinical, operational and financial data delivered to healthcare professionals within their workflows in near real time. This data asset serves as the foundation for a growing number of innovative healthcare applications developed by Caradigm and industry partners, providing rapid incremental value to customers.
About LexisNexis Risk Solutions
LexisNexis Risk Solutions (www.lexisnexis.com/risk/) is a leader in providing essential information that helps customers across industries and government predict, assess and manage risk. Combining cutting-edge technology, unique data and advanced analytics, Risk Solutions provides products and services that address evolving client needs in the risk sector while upholding the highest standards of security and privacy. LexisNexis Risk Solutions is part of Reed Elsevier, a leading global provider of professional information solutions across a number of sectors. Our health care solutions assist payers, providers and integrators with ensuring appropriate access to health care data and programs, enhancing disease management contact ratios, improving operational processes, and proactively combating fraud, waste and abuse across the continuum.